COVID-19 Vaccines: Novavax Gets Reprieve With US FDA Panel Supporting JN.1 Formulation

 
• By Sue Sutter
  
Tree trunk
A JN.1 vaccine will target the trunk of the tree, not the branches, a CDC official said. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers